This course includes the webinar and SAM credit


This webinar will address current concepts in the realm of cell free DNA testing for cancer, with an emphasis on the role of plasma-based testing in patients with non small cell lung carcinoma. Topics to be covered include: the process for validating and implementing cfDNA testing in the hospital setting, the clinical role for cfDNA testing in cancer patients with an emphasis on EGFR-mutated lung carcinoma, and approaches to next generation sequencing for cfDNA.  Practical issues will be emphasized, including clinical performance characteristics of available assays and specimen handling considerations. Selected studies demonstrating the future potential of cfDNA testing for cancer monitoring will be reviewed.

Speaker: Lynette M. Sholl, MD

Host: Anthony Snow, MD

Duration: 1 hr

Level of Instruction: Basic

Last day to purchase course and claim credit: September 25, 2020

How to Claim Credit

To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 75% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

SAM Credit

This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

* You may not submit SAMs and CME/CMLE credit for the same content.

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Course Information
Course Date:
September 25, 2017
Course Objectives
  • Identify the challenges of validation and implementation of cfDNA testing in the clinical laboratory.
  • Describe the utility and approach of targeted genotyping versus next generation sequencing from cfDNA.
  • Describe the clinical need for alternatives to tumor tissue testing and the current role for cell free DNA diagnostics in lung cancer.
  • Describe approaches to cfDNA assay design and validation.
Cell Free DNA Testing for Cancer: Clinical Validation, Implementation and Applications
Speaker Information
Lynette M. Sholl MD   [ view bio ]
Individual topic purchase: Selected
American Board of Pathology
Self-Assessment Module: 1.00
Webinar + SAM
AMP Regular Member: $10.00
AMP Technologist Member: $10.00
AMP Associate Member: $10.00
Non-member Price: $215.00